跳至主要内容
临床试验/ITMCTR2000003059
ITMCTR2000003059招募中未知

Study on Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19) With Traditional Chinese Medicine

China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • (1) Comply with the diagnostic criteria for general type COVID-19 in the Diagnosis and Treatment Program for COVID-19(trial version 6th).
  • (2) Aged >= 18 years.
  • (3) Agree to participate in the trial, and the patient, the legal guardian or the person in charge of the medical institution signed the informed consent through paper signature, electronic signature of mobile phone software, or voice authorization.

排除标准

  • (1) Critical patients.
  • (2) Patients who can not guarantee compliance of using TCM during the treatment period, or patients who are difficult to take medicine by oral or nasal route.
  • (3) Patients with severe primary respiratory disease or other pathogenic microbial pneumonia that needs to be identified with COVID-19.
  • (4) Pregnant or parturient women. Patient who have a pregnancy plan or a positive urine pregnancy test.
  • (5) Patients with other systemic malignant diseases such as malignant tumors, mental illnesses, etc., which the researchers consider unsuitable for participation in the trial.
  • (6) Patients who have been allergic or intolerant to taking TCM.

研究者

相似试验